Mobilion Systems

company

About

MOBILion Systems specializes in identifying and analyzing challenging molecules that other instruments so far have failed to detect.

Details

Last Funding Type
Series A
Last Funding Money Raised
$15.40M
Industries
Analytics,Biotechnology,Life Science,Therapeutics
Founded date
Jan 1, 2015
Operating Status
Active

MOBILion Systems is a biotechnology company that specializes in identifying and analyzing the most challenging molecules that other instruments fail to detect. Its technology focuses on biologic therapeutics, discovering biomarkers, and improving the accuracy of diagnostic tests.MOBILion’s technology makes it easy to separate, identify, and analyze the most challenging molecules that other instruments fail to detect. The company's analytical instruments provide unprecedented sensitivity, resolution, and throughput that will fuel the development of better therapeutics, the ability to detect disease earlier, and the power to attack diseases at their roots instead of their symptoms.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$110.40M
Mobilion Systems has raised a total of $110.40M in funding over 2 rounds. Their latest funding was raised on Jul 13, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 13, 2021 Series C $60M 1 Detail
Aug 17, 2020 Series B $35M 1 Detail
Nov 12, 2019 Series A $15.40M 1 Agilent Technologies Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Mobilion Systems is funded by 1 investors. Agilent Technologies are the most recent investors.
Investor Name Lead Investor Funding Round
Agilent Technologies Series C